SAN FRANCISCO, November 26, 2015 /PRNewswire/ --
Global 3D bioprinting market is expected to reach
USD 1.82 billion by 2022, according
to a new report by Grand View Research Inc. Rising prevalence of
chronic diseases such as Chronic Kidney Disease (CKD) which demands
kidney transplantation is expected to boost the market growth, as
3D bioprinting is convenient and cost effective substitute for
organ transplantation.
(Logo:
http://photos.prnewswire.com/prnh/20150105/723757)
Browse full research report with TOC on
"3D Bioprinting Market Analysis By Technology (Magnetic
Levitation, Inkjet Based, Syringe Based, Laser Based), By
Application (Medical, Dental, Biosensors, Consumer/Personal Product
Testing, Bioinks, Food And Animal Product Bioprinting) And Segment
Forecasts To 2022" at:
http://www.grandviewresearch.com/industry-analysis/3d-bioprinting-market
Emerging medical applications of 3D bioprinting such as toxicity
testing, drug discovery, tissue engineering and consumer product
testing are expected to further drive the market growth positively.
Increasing R&D expenditure is anticipated to be high impact
rendering driver for the industry. 3D bioprinting advances in
tissue engineering and allows developments to be done using
biomaterials which have better biocompatibility. Moreover, rising
geriatric population is expected to assist the market growth, as
this demographic is highly susceptible to age related organ
deformities.
Further key findings from the report suggest:
- Syringe based printers dominated the technology segment as
these printers allow working in sterile environment. Moreover,
syringe based printers have wide applications which include
fabrication of scaffolds, cell strips printing, and tissue
printing.
- Magnetic levitation based printers are expected to witness
lucrative growth over the forecast period. This can be attributed
to emerging medical applications such as screening of
cardiovascular toxicity, human cell modeling and smooth muscle
printing.
- The medical applications segment is expected to gain
substantial share of over 32.0% by 2022 which can be attributed to
emerging applications of 3D bioprinting such as toxicity screening,
organ transplants and medical pills.
- Dental application segment is expected to witness lucrative
growth over the forecast period. Rising demand for cosmetic
dentistry along with growing awareness about oral hygiene are
expected to foster the demand for dental applications.
- North America dominated the
regional 3D bioprinting market with over 35.0% share and is
expected to grow at a CAGR of 10.0%. Supportive government
initiatives to improve healthcare infrastructure coupled with
growing disposable income are vital driving factor for this
region's growth.
- Asia Pacific is expected to
witness lucrative growth over the forecast period. Favorable
government support to improve healthcare delivery with economic
developments in emerging countries such as India and China are expected to increase the demand for
3D bioprinting.
- Key players operating in the 3D bioprinting industry include
Organovo Holding Inc., Cyfuse Biomedical, BioBots, Luxexcel Group
BV, TeVido BioDevices, Aspect Biosystems, 3Dynamics Systems,
Stratasys Ltd., Voxeljet, Oceanz, Materialise NV, Envision TEC,
Bio3D Technologies, Solidscape and others.
- These players are involved in various strategic initiatives
such as new product launches, strategic alliances and mergers and
acquisitions to gain the edge over the competitors. For instance,
In June 2015, Orgonovo collaborated
with L'Oreal to develop skin tissue using NovoGen Bioprinting
platform.
Grand View Research has segmented the global 3D bioprinting
market on the basis of products and region:
- 3D Bioprinting Market Technology Outlook (USD million),
2012 - 2022
- Magnetic levitation
- Inkjet based
- Syringe based
- Laser based
- Other
- 3D Bioprinting Market Application Outlook (USD million),
2012 - 2022
- Medical
- Tissue and organ generation
- Medical pills
- Prosthetics and implants
- Dental
- Biosensors
- Consumer/Personal products testing
- Bioinks
- Food and animal product bioprinting
- 3D Bioprinting Market Regional Outlook (USD million),
2012 - 2022
- North America
- Europe
- Asia Pacific
- Latin America
- MEA
Browse related reports by Grand View Research:
- Advanced Parenteral Drug Market -
http://www.grandviewresearch.com/industry-analysis/advanced-parenteral-drug-market
- IV Therapy and Vein Access Devices Market -
http://www.grandviewresearch.com/industry-analysis/iv-therapy-and-vein-access-devices-market
- Medical Plastics Market -
http://www.grandviewresearch.com/industry-analysis/medical-plastics-market
- Medical Aesthetics Market -
http://www.grandviewresearch.com/industry-analysis/medical-aesthetics-market
About Grand View Research
Grand View Research, Inc. is a U.S. based market research and
consulting company, registered in the State of California and headquartered in
San Francisco. The company
provides syndicated research reports, customized research reports,
and consulting services. To help clients make informed business
decisions, we offer market intelligence studies ensuring relevant
and fact-based research across a range of industries, from
technology to chemicals, materials and healthcare.
Read Our Blogs - dniamericas.org,
divog.org
Contact:
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc
Phone: 1-415-349-0058
Toll Free: 1-888-202-9519
Email: sales@grandviewresearch.com
Web: http://www.grandviewresearch.com